Physician profile
David E Strom
NPI 1609883511
$13,284.35
in general payments reported to CMS, 2019-2025
27 companies · $285 in 2025
The $285 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,867 · 2020: $5,096 · 2021: $2,664 · 2022: $361 · 2023: $1,854 · 2024: $158 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,525 · Travel and Lodging: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,525.19 |
| Travel and Lodging | $771.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,582.52 | 2019-2020 | |
| Vilex LLC | $2,366.86 | 2021 | |
| Linvatec Corporation | $976.13 | 2023 | Colink Neofuse, Quantum, Colink 2 |
| Southtech Orthopedics | $775.52 | 2020 | |
| Tricoast Surgical Solutions LLC | $617.20 | 2022-2023 | |
| Next Science LLC | $540.91 | 2020 | |
| Smith+Nephew, INC. | $418.23 | 2019-2024 | Stravix Pl, Oasis, Grafix |
| Organogenesis INC. | $378.23 | 2021-2024 | Puraply |
| Treace Medical Concepts, INC. | $209.54 | 2020-2024 | |
| Exactech, INC. | $209.37 | 2019-2023 | |
| Paratek Pharmaceuticals, INC. | $196.82 | 2025 | Nuzyra |
| Innovation Technologies INC | $194.03 | 2023-2024 | Irrisept |
| Kerecis Limited | $171.30 | 2020-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $142.64 | 2019 | |
| Integra Lifesciences Corporation | $102.55 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Normatec Industries, Lp | $78.81 | 2019 | |
| Paragon 28, INC. | $73.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $65.78 | 2023 | Bioresorbables |
| Kci USA, INC. | $35.93 | 2019 | |
| Medartis INC. | $25.11 | 2022 | |
| Cashflow Solutions, LLC | $24.96 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Endo Pharmaceuticals INC. | $21.37 | 2022 | |
| Abbvie INC. | $18.65 | 2025 | |
| Solventum Corporation | $18.60 | 2025 | Activ.A.C. |
| Aroa Biosurgery Incorporated | $15.77 | 2019 | |
| Pacira Therapeutics, INC. | $12.83 | 2019 | |
| Medtronic, INC. | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Strom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.